Gilead's Great Growth
562473
The drugmaker announces another great quarter of growth.
663200
The company continues its rapid growth, but investors want even more.
393883
Schering continues its strong sales and earnings growth.
275199
The office furniture maker is producing impressive growth overseas.
68266
Gilead gets marketing approval for one of its drug candidates.
693326
The database provider continues to buy its growth.
723686
FOSTER CITY, Calif. -- Gilead Sciences Inc., a drug research company, said Monday it plans to buy Myogen Inc. for about $2.5 billion in cash, giving Gilead access to Myogen's heart-drug candidates.
674411
This old media company is capitalizing on growth initiatives.
333076
Gilead Sciences Inc. , the world's third-biggest biotechnology company, said on Monday it agreed to acquire Myogen Inc.  for $2.5 billion in a surprise transaction that gives Gilead access to Myogen's experimental hypertension drugs.
132865
There's more to growth than just a high growth rate.
417603
The retailer reports another quarter of double-digit sales growth.
671315
Sometimes great growth is where you least expect it.
442537
Gilead Sciences Inc posted a third-quarter profit that topped Wall Street targets on Thursday, on sales of drugs that fight the virus that causes AIDS, compared with a year-ago net loss due to acquisition- related costs.
160226
The contract drug research company shares surged as the firm showed signs of new life.
563004
The retailer reports another stellar quarter.
349401
Amazing growing stories are waiting for you to discover them.
480772
Biotech company buys itself a bigger future.